Cellectis (CLLS) Capital Expenditures (2015 - 2026)
Cellectis (CLLS) posted Capital Expenditures of -$253,000 for Q2 2026, compared with -$305,000 a year earlier.
Powered by 
Analysis
Cellectis (CLLS) Capital Expenditures (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Cellectis was -$2.18 million; for FY2025, it came in at -$2.36 million.
- In prior years, Cellectis' Capital Expenditures was -$2.58 million in FY2024, -$1.07 million in FY2023, -$2.43 million in FY2022 and -$18.54 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Capital Expenditures since Q2 2024.
- According to Business Quant data, Capital Expenditures for the three prior quarters was -$265,000 (Q1 2026), -$479,000 (Q4 2025) and -$1.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Cellectis | 147.50 Mn | -605.90 Mn | - | -253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -253,000.00 |
| Mar 31, 2026 | -265,000.00 |
| Dec 31, 2025 | -479,000.00 |
| Sep 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -305,000.00 |
| Mar 31, 2025 | -395,000.00 |
| Dec 31, 2024 | -550,000.00 |
| Sep 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | -218,000.00 |
| Dec 31, 2023 | -276,000.00 |
| Sep 30, 2023 | -1.28 Mn |
| Jun 30, 2023 | 696,000.00 |
| Mar 31, 2023 | -213,000.00 |
| Dec 31, 2022 | -442,000.00 |
| Sep 30, 2022 | -3.53 Mn |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | -626,000.00 |
| Dec 31, 2021 | -289,000.00 |
| Sep 30, 2021 | -31.90 Mn |
API Access
Cellectis Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();